This system divides PCa patients into three different risk groups—low-risk (lrPCa), intermediate-risk (irPCa), and high-risk (hrPCa) PCa—according to serum PSA levels, Gleason score (GS) in the prostate biopsy, and clinical stage. Here, KLK3 is linked to posterior cortical atrophy.